Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Directory
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Sickle Cell Disease
Sort By
Newest First
1 / 1
Chronokines
Delivering Breakthrough Medicines for Rare Hematologic Diseases and Cancers
Emilie Branch; Frank D. Lee
Pharma's Almanac
PAP-Q2-20-CL-003
Jul 01, 2020
Novartis
FDA Acceptance
FDA Accepts File and Accelerates Review of Novartis Sickle Cell Disease Medicine Crizanlizumab (SEG101)
Novartis
PR-M07-19-NI-048
Jul 18, 2019
Sancilio & Company Inc.
Research
Sancilio Pharmaceuticals Company to Present New Research on Altemia™ to Treat Sickle Cell Disease at the ASPHO Conference
Sancilio & Company Inc.
PR-M05-18-NI-015-4333
May 03, 2018
1 / 1
